Didar Uçar

750 total citations
53 papers, 395 citations indexed

About

Didar Uçar is a scholar working on Ophthalmology, Rheumatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Didar Uçar has authored 53 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Ophthalmology, 17 papers in Rheumatology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Didar Uçar's work include Ocular Diseases and Behçet’s Syndrome (37 papers), Retinal and Optic Conditions (25 papers) and Vasculitis and related conditions (10 papers). Didar Uçar is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (37 papers), Retinal and Optic Conditions (25 papers) and Vasculitis and related conditions (10 papers). Didar Uçar collaborates with scholars based in Türkiye, United States and Italy. Didar Uçar's co-authors include Gülen Hatemi, Yılmaz Özyazgan, Cengiz Aras, Arif Koytak, Yusuf Yazıcı, Hüseyin Yetik, Emire Seyahi, Vedat Hamuryudan, Uğur Uygunoğlu and Sinem Nihal Esatoğlu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Didar Uçar

44 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Didar Uçar Türkiye 13 311 100 98 89 57 53 395
Arash Maleki United States 11 370 1.2× 83 0.8× 49 0.5× 55 0.6× 37 0.6× 50 423
Yüksel Süllü Türkiye 13 393 1.3× 72 0.7× 34 0.3× 111 1.2× 42 0.7× 35 472
Valentina Mastrofilippo Italy 12 381 1.2× 68 0.7× 63 0.6× 95 1.1× 38 0.7× 44 524
Rubbia Afridi United States 10 339 1.1× 90 0.9× 52 0.5× 75 0.8× 14 0.2× 34 378
Abdulbaki Mudun Türkiye 5 584 1.9× 223 2.2× 143 1.5× 78 0.9× 33 0.6× 7 646
Hassan Al-Dhibi Saudi Arabia 13 438 1.4× 55 0.6× 72 0.7× 162 1.8× 36 0.6× 49 507
G. Tokgöz Türkiye 10 170 0.5× 179 1.8× 84 0.9× 33 0.4× 21 0.4× 24 345
Akshay S. Thomas United States 12 369 1.2× 54 0.5× 29 0.3× 180 2.0× 35 0.6× 68 429
M. Frigui Tunisia 12 82 0.3× 202 2.0× 70 0.7× 41 0.5× 35 0.6× 41 349
Burkhard Wiechens Germany 12 249 0.8× 43 0.4× 21 0.2× 123 1.4× 37 0.6× 31 352

Countries citing papers authored by Didar Uçar

Since Specialization
Citations

This map shows the geographic impact of Didar Uçar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Didar Uçar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Didar Uçar more than expected).

Fields of papers citing papers by Didar Uçar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Didar Uçar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Didar Uçar. The network helps show where Didar Uçar may publish in the future.

Co-authorship network of co-authors of Didar Uçar

This figure shows the co-authorship network connecting the top 25 collaborators of Didar Uçar. A scholar is included among the top collaborators of Didar Uçar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Didar Uçar. Didar Uçar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Köker, Oya, Mehmet Yıldız, Fatih Haşlak, et al.. (2025). Noninfectious Uveitis in Pediatric Rheumatology. JCR Journal of Clinical Rheumatology. 31(5). 181–187.
2.
Uçar, Didar & Sinem Nihal Esatoğlu. (2025). Behçet syndrome with eye involvement. Saudi Journal of Ophthalmology. 39(1). 47–53.
4.
Özgüler, Yeşim, Sinem Nihal Esatoğlu, Didar Uçar, et al.. (2024). Validation of the Behçet’s Syndrome Overall Damage Index (BODI) for retrospective studies and a proposal for modification. Lara D. Veeken. 64(3). 1309–1315. 2 indexed citations
5.
Hatemi, Gülen, Didar Uçar, Uğur Uygunoğlu, Hasan Yazıcı, & Yusuf Yazıcı. (2023). Behçet Syndrome. Rheumatic Disease Clinics of North America. 49(3). 585–602. 14 indexed citations
6.
Uçar, Didar, Sinem Nihal Esatoğlu, Vedat Hamuryudan, et al.. (2023). Mycophenolate mofetil may be an alternative for maintenance therapy of Behçet syndrome uveitis: a single-center retrospective analysis. Rheumatology International. 43(11). 2099–2106. 2 indexed citations
7.
Uçar, Didar, et al.. (2023). Coincident Acute Macular Neuroretinopathy and Paracentral Acute Middle Maculopathy in COVID-19. Turkish Journal of Ophthalmology. 53(2). 120–123. 2 indexed citations
8.
Uçar, Didar, et al.. (2023). Quantitative microvascular alterations in butterfly-shaped pattern dystrophy and adult-onset foveomacular vitelliform dystrophy. Journal Français d Ophtalmologie. 47(2). 103977–103977.
9.
Kasapçopur, Özgür, et al.. (2022). Case–control study of corneal topography and specular microscopy parameters in JIA patients with and without ocular involvement. International Ophthalmology. 43(2). 635–641. 1 indexed citations
10.
Uygunoğlu, Uğur, Didar Uçar, Serdal Uğurlu, et al.. (2022). Safety of SARS-CoV-2 vaccination in patients with Behcet’s syndrome and familial Mediterranean fever: a cross-sectional comparative study on the effects of M-RNA based and inactivated vaccine. Rheumatology International. 42(6). 973–987. 17 indexed citations
11.
Sarıcı, Ahmet, et al.. (2022). Episcleral Iodine-125 radioactive plaque brachytherapy as a salvage treatment for retinoblastoma in the era of intraarterial chemotherapy. The Turkish Journal of Pediatrics. 64(2). 285–292. 2 indexed citations
12.
Uçar, Didar, et al.. (2022). Evaluation of Retinal Microvascular Impairment after COVID-19 and its Clinical Correlates Using Optical Coherence Tomography Angiography. Turkish Journal of Ophthalmology. 52(5). 324–330. 5 indexed citations
13.
Yılmaz, Erkan, et al.. (2022). Higher antibody responses after mRNA-based vaccine compared to inactivated vaccine against SARS-CoV-2 in Behcet’s syndrome. Rheumatology International. 42(10). 1741–1750. 3 indexed citations
14.
Sarıcı, Ahmet, et al.. (2021). Comparison of iodine-125 plaque brachytherapy and gamma knife stereotactic radiosurgery treatment outcomes for uveal melanoma patients. Graefe s Archive for Clinical and Experimental Ophthalmology. 260(4). 1337–1343. 7 indexed citations
15.
Uçar, Didar, et al.. (2020). Investigation of clinical profile of Behçet's syndrome-related versus idiopathic branch retinal vein occlusion. Indian Journal of Ophthalmology. 68(9). 1876–1876. 1 indexed citations
16.
Özgüler, Yeşim, Didar Uçar, Murat Kasap, et al.. (2019). Peripheral blood mononuclear cell proteome profile in Behçet’s syndrome. Rheumatology International. 40(1). 65–74. 6 indexed citations
17.
Sen, H. Nida, et al.. (2014). Gender Disparities in Ocular Inflammatory Disorders*. Current Eye Research. 40(2). 146–161. 25 indexed citations
18.
Özyazgan, Yılmaz, Didar Uçar, Gülen Hatemi, & Yusuf Yazıcı. (2014). Ocular Involvement of Behçet’s Syndrome: a Comprehensive Review. Clinical Reviews in Allergy & Immunology. 49(3). 298–306. 44 indexed citations
19.
Balcı, Huriye, et al.. (2008). Primer açık açılı glokomlu ve senil kataraktlı hastalarda oksidatif stresin rolü. Turkish Journal of Ophthalmology. 38(4). 292–297. 1 indexed citations
20.
Güven, Mehmet, Mustafa Ünal, Bahadır Batar, et al.. (2007). Polymorphisms of DNA repair genes XRCC1 and XPD and risk of primary open angle glaucoma (POAG).. PubMed. 13. 12–7. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026